INSIGHTS ON DRUG DEVELOPMENT

• Microflow Columns Boost GLP-1 Sensitivity And Reduce Solvent

  Microflow chromatography offers a practical way to boost GLP‑1 assay sensitivity while cutting solvent use. See how 1.0 mm columns improve peak response without sacrificing chromatographic performance.

• Advancing GLP-1 Analog Drug Development Using A Variety Of Techniques

  Discover how SEC-MALS reveals the aggregation behavior of GLP-1 analogs like semaglutide and liraglutide, which are critical for ensuring the stability, efficacy, and safety of peptide therapeutics.

• Scale Your Viral Vector Production With A Streamlined Bioreactor System

  Scale your viral vector or vaccine production with a streamlined, intermediate-scale bioreactor system that bridges development and commercial manufacturing, supporting applications from exosomes to vaccines.

• Overcoming Challenges In Ophthalmic Formulations Through Polymer Selection

  The growing demand for ophthalmic drugs is driven by aging populations and increased screen time, which contributes to rising eye conditions. Explore innovative solutions in ophthalmic drug development.

• The Delicate Dance: When Phase-Appropriate Decisions Carry More Risk

  9/23/2026

   Early drug development demands speed, but some decisions carry long-term consequences. Learn which process and analytical choices require teams to look beyond the next milestone.

• Redefining OSD Development Through Foresight And Innovation

  2/12/2026

  From early formulation challenges to scale-up and commercial readiness, proactive planning and integrated capabilities help teams anticipate risks, accelerate decision-making, and maintain momentum across development.

• Manufacturing CAR T Cell Therapies: Challenges, Insights And Solutions

  6/16/2025

  Manufacturing patient-specific cell therapies is a complex, multi-step process. Addressing key hurdles in production time, scalability, and cost is crucial to making these vital treatments more accessible.

• How The Accelerator™ Drug Development Model Enhances eNPV

  2/25/2026

  Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.

• Development Of Separation Methods for GLP-1 Synthetic Peptides

  6/27/2025

  Peptides offer precise, low-cost therapeutic potential, especially in GLP-1 drugs for diabetes and weight loss. A new HPLC-UV/MS method ensures consistent quality and analysis of these compounds.